3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Hepatocellular
121
Carcinoma, Renal Cell
60
Neoplasms
43
Liver Neoplasms
42
Neoplasm Metastasis
23
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
20
Melanoma
18
Kidney Neoplasms
16
Breast Neoplasms
16
Brain Neoplasms
13
Pancreatic Neoplasms
12
Sarcoma
11
Prostatic Neoplasms
10
Glioblastoma
10
Lung Neoplasms
9
Thyroid Neoplasms
8
Recurrence
8
Rectal Neoplasms
8
Colorectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Colonic Neoplasms
7
Stomach Neoplasms
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Leukemia
6
Gliosarcoma
6
Carcinoma
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Urinary Bladder Neoplasms
4
Interventions
COVID-19 Vaccines
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Standard of Care
3
2019-nCoV Vaccine mRNA-1273
3
Pandemic Preparedness
2
sotrovimab
1
sinovac COVID-19 vaccine
1
selinexor
1
regorafenib
1
proxalutamide
1
monalizumab
1
lenzilumab
1
ciclesonide
1
bemcentinib
1
avdoralimab
1
acalabrutinib
1
XAV-19
1
Surgical Procedures, Operative
1
Sperm Count
1
Specimen Handling
1
Sorafenib
1
Sodium Chloride
1
Rabeprazole
1
Patient Reported Outcome Measures
1
Observation
1
Nutritional Status
1
Niclosamide
1
Meopa
1
Mastectomy, Segmental
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
COVID-19
×
Sorafenib
×
Clear all
NCT05594147
2023-11-07
ROCURS
Bayer
Completed
4,103 enrolled